Study on corticostriatal synapse ultrastructure and function in rats with levodopa induced dyskinesias

Chinese Journal of Neurology

Volumn 37, Issue 2, 2004, Pages 126-130

  Cao, Xue Bing ^a   Sun, Sheng Gang ^a   Wang, Lan ^a   Xu, Yan ^a   Tong, E Tang ^a   Yuan, Guang Lei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Dyskinesias; Levodopa; Mutation; Parkinson disease; Rats; Visual cortex

Indexed keywords

6 HYDROXYDOPA; BENSERAZIDE; DIZOCILPINE; GLUTAMIC ACID; LEVODOPA; LEVODOPA METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CORTICOSTRIATAL TRACT; DENSITY; DISEASE MODEL; DYSKINESIA; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSONISM; PATHOGENESIS; RAT; STRIATE CORTEX; SYNAPSE; SYNAPTIC TRANSMISSION; VISUAL CORTEX;

EID: 3543054557     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Olanow CW, Obeso JA. Preventing levodopa-induced dyskinesias. Ann Neurol, 2000, 47Suppl 1:S167-S178.
2. Thomas J, Wang J, Takuba H, et al. A 6-OHDA induced selective Parkinsonian rat model: further biochemical and behavioural characterization. Exp Neurol, 1994, 126:159-167.
3. Lee CS, Cenei MA, Schulzer M, et al. Embryonic ventral mesencephalic grafts improve levodopa - induced dyskinesia in a rat model of Parkinson's disease. Brain, 2000, 123:1365-1379.
4. Guldner FH, Ingham CA. Increase in postsynaptic density material in optic target neuron of the rat suprachiasmatic nucleus after bilateral enucleation. Neurosci Lett, 1980, 17:27-31.
5. Ingham CA, Hood SH, Taggart P, et al. Plasticity of synapse in the rat neostriatum after unilateral lesion of the nigrostriatal dopamine pathway. J Neurosci, 1998, 18:4732-4743.
6. Anglade P, Mouati-Prigent A, Agid Y, et al. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration, 1996, 5:121-128.
7. Yamauchi T. Molecular constituents and phosphorylation-dependent regulation of the post-synaptic density. Mass Spectrum Rev. 2002, 21:266-286.
8. Soderling TR, Derkach VA. Postsynaptic protein phosphorylation and LTP. Trends Neurosci, 2000, 23:75-80.
9. Okabe S. NMDA receptors and their interacting proteins in the post synaptic density. Kaibogaku Zasshi, 2001, 76:185-191.
10. Jones DG, Harris RJ. An analysis of contemporary morphological concepts of synaptic remodelling in the CNS: perforated synapses revisited. Rev Neurosci, 1995, 6:177-219.
11. Toni N, Buchs PA, Nikonenko I, et al. Remodelling of synaptic membranes after induction of long-term potentiation. J Neurosci, 2001, 21:6245-6251.
12. Henry B, Crossman AR, Brotchie JM. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Exp Neurol, 1998, 151:334-342.
13. Calabresi P, Giacomini P, Centonze D, et al. Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol, 2000, 4 Suppl 1:S60-S69.
14. Calabresi P, Pisani A, Mercuri NB, et al. The corticostriatal projection from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci, 1996, 19:19-24.